Skip to main content
. Author manuscript; available in PMC: 2022 Feb 1.
Published in final edited form as: Cell Signal. 2020 Dec 6;78:109879. doi: 10.1016/j.cellsig.2020.109879

Fig. 1.

Fig. 1.

Disorders resulting from mutational defects in the lysosomal sphingolipid degradation pathway. Oligosaccharide structures are illustrated by colored symbols. Substrate names are presented in gray rounded boxes, genes are presented in green text, and disorders are presented in boxed red arrows. An asterisk (*) identifies a disease predisposition associated with a gene variant.